Summary
The effects of streptozotocin-induced diabetes on the vitamin D metabolism of pregnant rats were investigated in mothers and their fetuses, 11 and 14 days after streptozotocin (SZ) injection, i.e., on days 18 and 21 of gestation. In the mothers' plasma, the levels of 25-hydroxycholecalciferol (25OHD) and 1,25-dihydroxycholecalciferol (1,25(OH)2 D) were not different from control levels on day 18, but on day 21, 25OHD had increased, 1,25 (OH)2 D had diminished, and significant hypercalcemia was noted (10.1±0.27 mg/dl vs. 9.47±0.19 mg/dl, mean ±SD). In hyperglycemic fetuses from the diabetic mothers, plasma insulin levels were reduced at day 18 but enhanced at day 21. 25OHD levels were not different from those of the controls at day 18, but were lower at day 21 (2.12±0.70 ng/g BW, n=13, vs. 3.75±1.40 ng/g BW n=29 controls, means ±SD). Fetal body levels of 1,25 (OH)2 D were lower than that in the controls at day 18 (16.6±2.9 pg/g BW, n=9×2, vs. 28.7±6.3 pg/g BW, n=7×2, mean ±SDP <0.001), but identical to control levels on day 21. The role of fetal or placental enzymes in the regulation of vitamin D metabolism in fetuses is discussed.
Similar content being viewed by others
References
Kumar R, Cohen WR, Silva P, Epstein FH (1979) Elevated 1,25 dihydroxyvitamin D plasma levels in normal human pregnancy and lactation. J Clin Invest 63:341–344
Pike JW, Parker JB, Haussler MR, Boass A, Toverud SU (1979) Dynamic changes in circulating 1,25 dihydroxyvitamin D during reproduction in rats. Science 204:1427–1429
Halloran BP, De Luca HF (1980) Calcium transport in small intestine during pregnancy and lactation. Am J Physiol 239:G473-G479
Verhaeghe J, Bouillon R, Nyomba BL, Lissens W, Van Assche A (1986) Vitamin D and bone mineral homeostasis during pregnancy in the diabetic BB rat. Endocrinology 118:1019–1025
Schneider LE, Schedl HP, Mc Cain T, Haussler MR (1977) Experimental diabetes reduced circulating 1,25 dihydroxyvitamin D in the rat. Science 196:1452–1454
Wilson HD, Horst RL, Schedl HP (1982) Calcium intake regulates 1,25-dihydroxyvitamin D formation in the diabetic rat. Diabetes 31:401–405
Seino Y, Gennari C, Avioli LV (1982) Effect of glucocorticoids on the intestinal 1,25(OH)2D3 receptor in rats. Calcif Tissue Int 34:585–589
Spencer EM, Khalil M, Tobiassen O (1980) Experimental diabetes in the rat causes an insulin reversible decrease renal 25 hydroxyvitamin D3 1α hydroxylase activity. Endocrinology 107:300–305
Sulimovici S, Roginsky MS (1979) Effect of diabetes in rats on the metabolism of cholecalciferol and 25-hydroxycholecalciferol. In: Norman AN, Schaefer K (eds) Vitamin D. Basic research and its clinical application. de Gruyter, Berlin, pp 979–982
Lester GE, Vanderwiel CJ, Kenney-Gray T, Talmage RV (1982) Vitamin D deficiency in rats with normal serum calcium concentrations. Proc Natl Acad Sci (USA) 79:4791–4794
Pitkin RM, Plank CJ, Filer LJ (1971) Fetal and placental composition in experimental maternal diabetes. Proc Soc Exp Biol Med 183:163–166
Eriksson UJ, Jansson JL (1984) Diabetes in pregnancy decreased placental blood flow and disturbed fetal development in the rat. Pediatr Res 18:735–738
Chen PS, Toribara TY, Warner H (1956) Microdetermination of phosphorus. Anal Chem 28:1756–1758
Adams JS, Clemens TL, Hollick MF (1981) Silica Sep Pak preparative chromatography for vitamin D and its metabolites. J Chromatogr 226:198–201
Haddad JG, Chyu KJ (1971) Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J Clin Endocrinol Metab 33:73–74
Shepard RM, DeLuca H (1980) Determination of vitamin D and its metabolites in plasma. In: McCornick DB, Wright LD (eds) Methods in enzymology. Academic Press, New York, pp 393–414
Adams JS, Sharma OP, Gacad MA, Singer FR (1983) Metabolism of 25 hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Invest 72:1856–1860
Bouillon R, Van Assche A, Van Baelen H, Heyns W, De Moor P (1981) Influence of the vitamin D-binding protein on the serum concentration of 1,25 dihydroxyvitamin D3. J Clin Invest 67:589–596
Hough S, Russel JE, Teitelbaum SZ, Avioli LV (1982) Calcium homeostasis in chronic streptozotocin-induced diabetes mellitus in the rat. Am J Physiol 242:E451–456
Heath H, Lambert PW, Service FS, Arnaud SB (1975) Calcium homeostasis in diabetes mellitus. J Clin Endocrinol Metab 49:462–466
Sulimovici S, Roginsky MS (1980) Hepatic metabolism of vitamin D3 in streptozotocin-induced diabetic rat. Acta Endocrinol 93:346–350
Hough S, Fausto A, Sonn Y, Dong Jo K, Birge SJ, Avioli LV (1983) Vitamin D metabolism in the chronic streptozotocin-induced diabetic rat. Endocrinology 113:793–796
Tanaka Y, De Luca HF (1973) The control of 25 hydroxyvitamin D metabolism by inorganic phosphorus. Arch Biochem Biophys 154:566–568
Wongsurawat N, Armbrecht JH, Zenser TV, Davis BB, Thomas ML, Forte LR (1983) 1,25-dihydroxyvitamin D3 and 24,25 dihydroxyvitamin D3 production by isolated renal slices is modulated by diabetes and insulin in the rat. Diabetes 32:302–306
Nyomba BL, Bouillon R, Lissens W, Van Baelen H, De Moor P (1985) 1,25 dihydroxyvitamin D and vitamin D binding protein are both decreased in streptozotocin diabetic rats. Endocrinology 116:2483–2488
Henry HL (1981) Insulin permits parathyroid hormone stimulation of 1,25 dihydroxyvitamin D3 production in cultured kidney cells. Endocrinology 108:733–735
Seino Y, Sierra RJ, Sonn YM, Jafari A, Birge SJ, Avioli LV (1980) The duodenal 1,25 dihydroxyvitamin D3 receptor in rats with experimentally induced diabetes. Endocrinology 113:1721–1725
Kamoun AJ (1970) Activité cortico-surrénale au cours de la gestation, de la lactation et du développement pré et postnatal chez le rat. I. Concentration et cinétique de disparition de la corticostérone. J Physiol (Paris) 62(5):32–35
Schedl HP, Heath H, Wenger J (1978) Serum calcitonin and parathyroid hormone in experimental diabetes: effects of insulin treatment. Endocrinology 103:1368–1373
Prager R, Abramovici A, Liban E, Laron Z (1974) Histopathological changes in the placenta of streptozotocin-induced diabetic rats. Diabetologica 19:89–91
Kervan A, Guillaum M, Jost A (1978) The endocrine pancreas of the fetus from diabetic pregnant rat. Diabetologica 15:387–393
Watts X, Gain K, Sandin PL (1976) Glucose homeostasis in the developing rats. Biol Neonate 30:88–94
Lester GE, Gray TK, Lorenc RS (1978) Evidence for maternal and fetal differences in vitamin D metabolism. Proc Soc Exp Biol Med 159:303–307
Ron M, Levitz M, Chuba J, Dancis J (1984) Transport of 25-hydroxyvitamin D3 across the perfused human placenta. Am J Obstet Gynecol 148:370–374
Plourde V, Haddad P, Gascon-Barré (1985) Microsomal C-25 hydroxylation of (3H) vitamin D3 by the fetal and neonatal rat liver. Pediatr Res 19:1206–1210
Eriksson U, Andersson A, Efendic S, Elde R, Claes H (1980) Diabetes in pregnancy: effects on the fetal and newborn rat with particular regard to body weight, serum insulin concentration and pancreatic contents of insulin, glucagon and somatostatin. Acta Endocrinol 94:354–364
Garabédian M, Nguyen TM, Halhali A, Guillozo H, Merlot AM, Cournot-Witner G, Chaker-Hosseini R, Balsan S (1982) Maternal and foetal3H-25(OH)D3 metabolism during rat pregnancy: sites of in vitro conversion and evolution from the 16th to the 21st day. Vitamin D, chemical, biochemical endocrinology of calcium metabolism. Walter et Gruyter, pp 133–138
Halhali A, Nguyen TM, Guillozo H, Garabédian M, Balsan S (1985) Maternal and fetal plasma vitamin D metabolites in the rat between days 16 and 21 of gestation. Vitamin D—a chemical, biochemical and clinical cifdate. Walter et Gruyter, pp 632–633
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Demignon, J., Rebut-Bonneton, C. Effects of experimental diabetes on the vitamin D metabolism of pregnant rats and their fetuses. Calcif Tissue Int 42, 127–135 (1988). https://doi.org/10.1007/BF02556345
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02556345